PARC Clinical Research

PARC has extensive experience in conducting clinical trials across a broad range of therapeutic areas and development stages, from Phase I through to Phase IV. PARC has extensive experience in the management of compounds with narrow therapeutic indices, such as opioids and products in the early phases of development, which often require specialised monitoring and management. In addition, PARC’s highly specialised clinical facility is equipped for intensive monitoring of high-risk therapies, with non-hospital allocated beds for overnight and participant studies. The facility’s expertise also extends to the dosing and handling of Schedule 8, intravenous, and infusion therapies.

Located within the Royal Adelaide Hospital and complementing other trials units within the Health Precinct, PARC has access to a large number of specialist clinicians, many of whom require a flexible and unique facility such as PARC to conduct their clinical research studies or who can provide patient referrals. PARC provides safe, high-quality facilities with ready access to clinicians and diagnostic services for the management of a wide range of medical conditions. The experienced nursing staff, combined with the research expertise of the unit, ensures that trials are conducted to the highest standards of care and safety.